Bibliography
- Papanikolaou EG, Kolibianakis E, Devroey P. Emerging drugs in assisted reproduction. Expert Opin Emerg Drugs 2005;10:425-40
- International Recombinant Human Chorionic Gonadotropin Study Group. Induction of ovulation in World Health Organization group II anovulatory women undergoing follicular stimulation with recombinant human follicle-stimulating hormone: a comparison of recombinant human chorionic gonadotropin (rhCG) and urinary hCG. Fertil Steril 2001;75:1111-18
- Chang P, Kenley S, Burns T, Recombinant human chorionic gonadotropin (rhCG) in assisted reproductive technology: results of a clinical trial comparing two doses of rhCG (Ovidrel) to urinary hCG (Profasi) for induction of final follicular maturation in in vitro fertilization-embryo transfer. Fertil Steril 2001;76:67-74
- Markle RL, King PJ, Martin DB, Characteristics of successful human chorionic gonadotropin (hCG) administration in assisted reproduction. Fertil Steril 2002;78:S71-2
- Bustillo M. Unsuccessful oocyte retrieval: technical artefact or genuine 'empty follicle syndrome'? Reprod Biomed Online 2004;8:59-67
- Stevenson TL, Lashen H. Empty follicle syndrome: the reality of a controversial syndrome, a systematic review. Fertil Steril 2008;90:691-8
- Driscoll GL, Tyler JP, Knight DC, Failure to collect oocytes in assisted reproductive technology: a retrospective. Hum Reprod 1998;13:84-7
- Christen M, Schertz JC, Arriagada P, The redesigned follitropin alpha pen injector for infertility treatment. Expert Opin Drug Deliv 2011;8:833-9
- Weiss N. Gonadotrophin products: empowering patients to choose the product that meets their needs. Reprod Biomed Online 2007;15:31-7
- Aghssa MM, Azargoon A, Ramezanzadeh F, A comparison of the efficacy, tolerability, and convenience of two formulations of follitropin-alpha in Iranian woman undergoing intracytoplasmic sperm injection cycles. Fertil Steril 2008;90:1043-8
- Somkuti SG, Schertz JC, Moore M, Patient experience with follitropin alfa prefilled pen versus previously used injectable gonadotropins for ovulation induction in oligoanovulatory women. Curr Med Res Opin 2006;22:1981-96
- Huisman D, Raymakers X, Hoomans EH. Understanding the burden of ovarian stimulation: fertility expert and patient perceptions. Reprod Biomed Online 2009;19(Suppl 2):5-10
- Schertz JC, Saunders H, Hecker C, The redesigned follitropin alfa pen injector: results of the patient and nurse human factors usability testing. Expert Opin Drug Deliv 2011;8:1111-20
- Abbotts C, Salgado-Braga C, Audibert-Gros C. A redesigned follitropin alfa pen injector for infertility: results of a market research study. Patient Prefer Adherence 2011;5:315-31
- Wiklund M. Usability Testing: Validating User Interface Design. Available from: http://www.mddionline.com/article/usability-testing-validating-user-interface-design [Last accessed 17 June 2011]
- International Organization of Standardization. Medical devices – application of risk management to medical devices. International Organization of Standardization; Geneva, Switzerland: 2007; Report No.: ISO 14971:2007
- Association for the advancement of medical instrumentation (AAMI). Human factors design process for medical devices. Association for the Advancement of Medical Instrumentation,; Arlington, VA: 2001; Report No.: ANSI/AAMI HE 74:2001
- National Health Service. Design for patient safety: user testing in the development of medical devices. 2010; NHS: National Patient Safety Agency UK
- Ovitrelle 250 micrograms/0.5 ml prefilled pen Summary of Product Characteristics. Available from: http://www.medicines.org.uk/EMC/medicine/25630/SPC/Ovitrelle+250+micrograms+0.5+ml+prefilled+pen/ [Last accessed 20 March 2012]
- Buhler K, Bals-Pratsch M, Blumenauer V, D.I.R Annual 2010 - German IVF-Registry. J Reproduktionsmed Endokrinol 2011;8:253-80